日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bellmunt Risk Score as a Prognostic Tool in Metastatic Castration-Resistant Prostate Cancer Survival

Bellmunt风险评分作为转移性去势抵抗性前列腺癌生存预后工具

Büttner, Thomas; Klümper, Niklas; Ellinger, Jörg; Ritter, Manuel; Krausewitz, Philipp

Bellmunt risk score enables survival prediction in men with metastatic castration resistant prostate cancer (mCRPC) undergoing PSMA-targeted radioligand therapy (LUMEN)

Bellmunt 风险评分能够预测接受 PSMA 靶向放射性配体治疗的转移性去势抵抗性前列腺癌 (mCRPC) 患者的生存情况 (LUMEN)

Büttner, Thomas; Marinova, Milka; Gaertner, Florian C; Kreppel, Barbara; Fritsche, Leander; Immanuel, Christian; Geraths, Gerd; Kürpig, Stefan; Küppers, Jim; Schmidt-Wolf, Ingo G H; Essler, Markus; Ritter, Manuel; Krausewitz, Philipp

Acquisition, image quality, and PI-RADS agreement of ultrahigh-gradient DWI in prostate 3-T MRI

前列腺3T磁共振成像中超高梯度DWI的采集、图像质量和PI-RADS一致性

Bischoff, Leon M; Endler, Christoph; Krausewitz, Philipp; Ellinger, Joerg; Klümper, Niklas; Isaak, Alexander; Mesropyan, Narine; Kravchenko, Dmitrij; Kuetting, Daniel; Sprinkart, Alois M; Mürtz, Petra; Pieper, Claus C; Luetkens, Julian A

[Management of isolated urinary bladder amyloidsis]

[孤立性膀胱淀粉样变性的治疗]

Seebold, Agneta; Büttner, Thomas; Fechner, Guido; Lau, Jan-Frederic; Krausewitz, Philipp

Association of fluid management during robotic-assisted radical laparoscopic prostatectomy with early surgical clinical outcomes: a risk factor for lymphoceles

机器人辅助腹腔镜根治性前列腺切除术中液体管理与早期手术临床结果的关系:淋巴囊肿的危险因素

Büttner, Thomas; Thudium, Marcus O; Ritter, Manuel; Hauser, Stefan; Söhle, Martin; Krausewitz, Philipp

TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy.

TROP-2 在乳头状肾细胞癌中的过度表达支持其作为抗体药物偶联疗法的治疗靶点的潜力

Kessler Carolina, von Brandenstein Melanie, Klümper Niklas, Krausewitz Philipp, Storz Enno, Rieger Constantin, Sperber Laurenz, Paffenholz Pia, Tolkach Yuri, Wirtz Ralph, Eckstein Markus, Heidenreich Axel, Weiten Richard

Ultra-high gradient performance 3-Tesla MRI for super-fast and high-quality prostate imaging: initial experience

超高梯度性能3特斯拉磁共振成像仪用于超快速、高质量的前列腺成像:初步经验

Bischoff, Leon M; Endler, Christoph; Krausewitz, Philipp; Ellinger, Joerg; Klümper, Niklas; Isaak, Alexander; Mesropyan, Narine; Kravchenko, Dmitrij; Nowak, Sebastian; Kuetting, Daniel; Sprinkart, Alois M; Mürtz, Petra; Pieper, Claus C; Attenberger, Ulrike; Luetkens, Julian A

Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach

利用基于甲基化的循环肿瘤DNA方法监测转移性前列腺癌治疗反应的可行性

Büttner, Thomas; Dietrich, Dimo; Zarbl, Romina; Klümper, Niklas; Ellinger, Jörg; Krausewitz, Philipp; Ritter, Manuel

Do we need MRI in all biopsy naïve patients? A multicenter cohort analysis

所有未接受过活检的患者都需要进行MRI检查吗?一项多中心队列分析

Krausewitz, Philipp; Borkowetz, Angelika; Ortner, Gernot; Kornienko, Kira; Wenzel, Mike; Westhoff, Niklas

Expression of the microtubule-associated protein 2 (MAP2) as a potential independent prognostic marker in prostate cancer.

微管相关蛋白 2 (MAP2) 的表达作为前列腺癌的潜在独立预后标志物

Stein Johannes, Krappe Eliana, Kremer Anika, Cronauer Marcus V, Essler Markus, Cox Alexander, Klümper Niklas, Krausewitz Philipp, Ellinger Jörg, Ritter Manuel, Kristiansen Glen, Majores Michael